Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.

Rice AE, Latchman YE, Balint JP, Lee JH, Gabitzsch ES, Jones FR.

Cancer Gene Ther. 2015 Sep;22(9):454-62. doi: 10.1038/cgt.2015.40. Epub 2015 Sep 4.

PMID:
26337747
2.

The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.

Koh AE, Njoroge SW, Feliu M, Cook A, Selig MK, Latchman YE, Sharpe AH, Colvin RB, Paul E.

J Autoimmun. 2011 Aug;37(1):48-57. doi: 10.1016/j.jaut.2011.03.004. Epub 2011 May 10.

3.

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Keszei M, Latchman YE, Vanguri VK, Brown DR, Detre C, Morra M, Arancibia-Carcamo CV, Paul E, Calpe S, Castro W, Wang N, Terhorst C, Sharpe AH.

Int Immunol. 2011 Feb;23(2):149-58. doi: 10.1093/intimm/dxq465. Epub 2011 Jan 28. Erratum in: Int Immunol. 2011 Jul;23(7):463. Arancibia, Carolina V [corrected to Arancibia-Carcamo, Carolina V].

4.

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.

Durgan K, Ali M, Warner P, Latchman YE.

Cancer Immunol Immunother. 2011 Apr;60(4):547-58. doi: 10.1007/s00262-010-0963-5. Epub 2011 Jan 15.

5.

Distinct changes in adult lymphopoiesis in Rag2-/- mice fully reconstituted by alpha4-deficient adult bone marrow cells.

Banerjee ER, Latchman YE, Jiang Y, Priestley GV, Papayannopoulou T.

Exp Hematol. 2008 Aug;36(8):1004-13. doi: 10.1016/j.exphem.2008.03.008. Epub 2008 May 12.

6.

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.

J Exp Med. 2006 Apr 17;203(4):883-95. Epub 2006 Apr 10.

7.

PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis.

Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, Freeman GJ, Sharpe AH.

Eur J Immunol. 2006 Jan;36(1):58-64.

8.

Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.

Keir ME, Latchman YE, Freeman GJ, Sharpe AH.

J Immunol. 2005 Dec 1;175(11):7372-9.

9.

Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.

Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, Guzior D, Latchman YE, Sayegh MH, Yagita H, Park CK, Oh SB, W├╝lfing C, Schatzle J, Mathew PA, Sharpe AH, Kumar V.

Blood. 2006 Apr 15;107(8):3181-8. Epub 2005 May 19.

10.

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.

Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10691-6. Epub 2004 Jul 12.

11.

Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.

Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, Sharpe AH.

Eur J Immunol. 2003 Oct;33(10):2706-16.

12.

Negative co-receptors on lymphocytes.

Greenwald RJ, Latchman YE, Sharpe AH.

Curr Opin Immunol. 2002 Jun;14(3):391-6. Review.

PMID:
11973140
13.

Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Jakob T, Huspith BN, Latchman YE, Rycroft R, Brostoff J.

Clin Exp Immunol. 1990 Mar;79(3):380-4.

14.

Circulating human leucocyte elastase levels in patients with pulmonary sarcoidosis.

Hind CR, Latchman YE, Brostoff J.

Sarcoidosis. 1988 Mar;5(1):38-42.

PMID:
2837822
15.

Effect of cardiopulmonary bypass on circulating concentrations of leucocyte elastase and free radical activity.

Hind CR, Griffin JF, Pack S, Latchman YE, Drake HF, Jones HM, Brostoff J, Dormandy TL, Treasures T.

Cardiovasc Res. 1988 Jan;22(1):37-41.

PMID:
3048690

Supplemental Content

Loading ...
Support Center